IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $744,000 | -88.0% | 150,000 | -88.5% | 0.68% | -12.2% |
| Q3 2022 | $6,214,000 | +176.2% | 1,300,000 | +160.0% | 0.78% | +243.8% |
| Q2 2022 | $2,250,000 | -63.9% | 500,000 | -61.8% | 0.23% | -45.7% |
| Q1 2022 | $6,237,000 | -35.9% | 1,310,340 | 0.0% | 0.42% | -21.4% |
| Q4 2021 | $9,723,000 | +757.4% | 1,310,340 | +555.2% | 0.53% | +979.6% |
| Q3 2021 | $1,134,000 | -79.5% | 200,000 | -83.3% | 0.05% | -78.8% |
| Q2 2020 | $5,520,000 | – | 1,200,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |